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Abstract: Gestation is regulated by an inflammatory 
 process that allows implantation and parturition. The com-
prehension of such inflammatory switches is important 
for the identification of therapeutic targets in pregnancy 
defects. Sphingolipids are a class of structural membrane 
components with important signaling functions. Among 
sphingolipids, ceramide is a well-known mediator of stress 
signals and pro-inflammatory responses. In this paper, we 
evaluated the association between ceramide increase and 
the inflammatory process of labor, comparing placentas 
from vaginal deliveries, including both spontaneous and 
induced labor, versus elective cesarean. We demonstrated 
that: (i) the inflammatory marker IL-6 is upregulated in 
labored placentas; (ii) IL-6 content inversely correlates 
with labor duration; (iii) ceramide content and expression 
of serine palmitoyl transferase (SPT, rate limiting enzyme 
for de novo ceramide synthesis) are increased in labored 
placentas; (iv) the expression of SPT directly correlates 
with inflammation and inversely with labor duration. 
These observations suggest that ceramide metabolism 
and signaling may be implicated in controlling important 
inflammatory mechanisms driving gestation: we hypoth-
esize that ceramide can be a therapeutic target in inflam-
matory complications of parturition.
Keywords: IL-6; serine palmitoyl transferase; sphingolipids.
Introduction
Gestation is a unique condition involving the maternal 
immune system, requiring the suppression of the own 
immune response for the acceptance of a semi-allogenic 
fetus, as well as the functionality of immune system for 
maternal and fetal protection from infection during preg-
nancy. A highly complex balance of signals drives the 
innate immune response through-out pregnancy: a pro-
inflammatory phase allowing blastocyst implanting into 
the uterus, a successive anti-inflammatory phase allowing 
fetal development and growth and a final acute inflamma-
tory phase allowing cervical ripening, uterine contraction 
and parturition (Mor et al., 2011). Excessive, persistent or 
deregulated maternal inflammatory responses result in 
adverse pregnancy outcomes and preterm birth is asso-
ciated with increased production of pro-inflammatory 
cytokines, chemokines and prostaglandins (Guleria and 
Pollard, 2000; Kramer et  al., 2009; Kunzmann et  al., 
2013). Likewise, Fetal Growth Restriction (Cotechini and 
Graham, 2015) and preeclampsia are associated with an 
exaggerated maternal inflammatory response. Moreover, 
a reduced production of anti-inflammatory mediators 
was detected in association with infertility, spontane-
ous sporadic or recurrent miscarriages and fetal under-
growth (Marzi et al., 1996; Piccinni et al., 1998; Kwak-Kim 
et  al., 2003; Hossein et  al., 2004; Fukui et  al., 2008; 
 Hanzlikova et al., 2009; Jin et al., 2011; Rolle et al., 2013). 
Thus, the comprehension of the regulation of inflamma-
tory switches represents an important acquisition for the 
identification of therapeutic targets in pregnancy defects 
as well as early markers of adverse outcomes. Pro-inflam-
matory lipids are functional components of the uterine 
stromal compartment remodeling, occurring in the early 
gestation  (Christiaens et  al., 2008). Sphingolipids are a 
broad class of structural membrane components endowed 
with important signaling activities. Among sphingolipids, 
ceramide is a well-known mediator of stress signals and 
pro-inflammatory responses. Ceramide can accumulate 
mainly in response to an external stress, inducing the 
catabolism of membrane sphingolipid, or to an endo-
genous stress leading to its increased de novo synthesis. 
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Sphingolipid altered metabolism occurs in cancer, degen-
erative and inflammatory diseases and few sphingolipid 
metabolism inhibitors are used in clinical trials (i.e. fin-
golimod, amitryptiline) (Nahrlich et  al., 2013; Kappos 
et  al., 2015). Sphingolipid metabolic rate is enhanced in 
early pregnancy in the first inflammatory implantation 
phase (Kaneko-Tarui et al., 2007). Similarly, at the end of 
pregnancy, the acute inflammation of labor and delivery 
was shown to involve sphingolipids signaling. Ceramide 
is a known activator of NF-κB, a transcription factor that 
controls the expression of many labor-associated genes 
including cyclooxigenase 2, prostaglandin-endoperoxide 
synthase 2 and the oxytocin receptor, together with other 
key inflammatory genes (Sykes et  al., 2014). It was also 
shown that ceramide accumulation mediates the inflam-
matory response in placenta by stimulating prostaglan-
dins 2 (PGE2) formation (Nakamura et al., 2001; Kawano 
et al., 2004; Sykes et al., 2014). Our group recently dem-
onstrated that de novo synthesis of ceramide is not only 
enhanced in acute lung inflammation but also supports it 
(Caretti et al., 2014). We proved that inflammatory stimuli 
induce an increased transcription of the rate limiting 
enzyme of ceramide synthesis (serine palmitoyl trans-
ferase, SPT) and that the pharmacological inhibition of 
this activity down regulates inflammatory response. SPT 
is a heterodimer composed of three subunits (SPTLC1, 2, 
3). Among the three subunits of SPT, forming the catalyti-
cally active site, SPTLC3 was shown to be highly expressed 
in placenta (Hornemann et  al., 2006). We here hypoth-
esize that up-regulation of ceramide synthesis actively 
takes part to the acute inflammatory phase driving labor. 
In this manuscript we showed that ceramide content and 
SPT expression are increased in placentas from vaginal 
delivery (both spontaneous and induced parturition) in 
respect with placentas from cesarean section. Moreover, 
the transcriptional control of SPT directly correlates with 
inflammation and inversely with labor duration.
Results
Inflammation is increased in placentas 
from vaginal delivery compared to elective 
cesarean section
Human labor is fundamentally an inflammatory process, 
characterized by the sudden expression of pro- inflammatory 
cytokines and chemokines, eliciting multiple downstream 
biological consequences that culminate in parturition. 
While elective cesarean section allows a delivery without 
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Figure 1: Labor-related inflammation increases in placentas from 
spontaneous and induced as compared to cesarean parturition.
IL-6 mRNA expression (panel A, left) and cytokine content (panel B, 
right) in placentas collected from women with spontaneous or 
induced onset of labor or from women who underwent cesarean 
parturition. RT-PCR and Elisa determinations of each sample have 
been performed in triplicate. Data on the graphs are expressed as 
fold increase vs. ct (cesarean parturition, stated as  = 1). Significance 
was evaluated by one-way ANOVA: p = 0.016 for mRNA expression; 
p = 0.014 for cytokine content. *p < 0.05 and **p < 0.01 vs. ct (Dunnett 
post-test). Panel (B) represents IL-6 protein expression (pg/ml) 
inversely correlated with the corresponding labor duration (min). 
Significance was evaluated by Linear correlation: p = 0.045, r2 = 0.17, 
n = 24.
placenta inflammation, spontaneous and induced vaginal 
delivery implies the labor related inflammation process. 
To investigate the inflammatory profile of human placenta 
from vaginal deliveries, we analyzed the mRNA and protein 
expression of IL-6 and TNF-α cytokines. As control, we 
chose placenta samples from elective cesarean section (with 
no labor occurrence). As expected, IL-6 mRNA (Figure 1A, 
left graph) was over-expressed in all vaginal deliveries, 
with the induced group showing higher expression than the 
spontaneous one, picking at threefold increase (*; vs. cesar-
ean section, p < 0.05, Dunnet post-test). In agreement with 
the transcriptional activity, the protein level of IL-6, meas-
ured by immunoassay technique in homogenated tissue, 
was increased in the induced versus cesarean section 
group (Figure 1A, right graph, **; p < 0.01, Dunnet post-test). 
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TNF-α mRNA expression was unaffected by the different 
parturition settings and the related protein was almost 
undetectable and considered ‘out of range below’ (data not 
shown). Moreover, IL-6 cytokine expression level inversely 
correlates with labor duration (p = 0.045) suggesting that 
inflammation is probably an acute event characterizing the 
labor process (Figure 1B).
Total ceramide content increases in 
placentas from vaginal delivery compared to 
elective cesarean section
In order to investigate a possible role of the pro- 
inflammatory sphingolipid ceramide in parturition, 
we evaluated the ceramide species content by LC-MS in 
 placentas. As shown in Figure 2A, total ceramide content 
almost doubled in vaginal deliveries vs. elective cesarean 
section, moving from 4.5±0.5 to 7.5±1.2 and 7.8±0.8, in 
spontaneous and induced group, respectively (*p < 0.05, 
Dunnet post-test). Single ceramide species expression 
is differently modulated. The less representative cera-
mides, namely C18:0 and C20:0 acyl-chain bearing cera-
mides (Figure 2B), are down-regulated in the spontaneous 
and induced group. Among the major ceramide species 
(Figure 2C), C16:0, C24:0 and C24:1 acyl-chain bearing 
ceramides are all significantly up-regulated (*p < 0.05; 
**p < 0.01 vs. cesarean, Dunnet post-test) thus accounting 
for the overall ceramide accumulation. No significant 
changes in sphingomyelin, hexosyl-ceramides, lactosyl 
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Figure 2: Total ceramide content is upregulated in placentas from spontaneous and induced as compared to cesarean parturition.
Total ceramide content (panel A), single ceramide species expression (panels B and C) and sphingomyelin (SM), hexosyl-ceramides 
(HexCer), lactosyl ceramide (LacCer), sphingosine (So), dihydrosphingosine (dhSo), panel (D) in placentas collected from women with 
 spontaneous or induced onset of labor or from women who underwent cesarean parturition, considered as the control. Note the different 
scale graph values between the minor (panel B) and the major (panel C) ceramide species represented. Ceramides were analyzed by LC-MS 
and expressed as pmol/mg biopsy. Significance was evaluated by one-way ANOVA: p = 0.035, for total ceramides; p = 0.041, for C16:0; 
p = 0.048, for C18:0; p = 0.041, for C20:0; p = NS, for C22:0; p = 0.044, for C24:0; p = 0.001, for C24:1. *p < 0.05 and **p < 0.01 vs. ct (Dunnett 
post-test).
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ceramide and dihydrosphingosine were identified among 
groups. A slight decrease in sphingosine was observed in 
the inflamed placentas.
Placenta ceramide accumulation is 
 associated to enhanced transcription of 
serine palmitoyl transferase (SPT), the 
enzyme controlling its de novo synthesis
SPT activity is related to a dimer formed mainly by SPTLC1 
and either SPTLC2 or 3. First, we evaluated the basic 
expression of SPT subunits in placentas from control elec-
tive cesarean section. Given that SPTLC1 is ubiquitously 
expressed, whereas the other two subunits are differen-
tially expressed in the various tissues, we evaluated the 
mRNA expression of the SPTLC2 and 3 in respect with 
SPTLC1. We observed that mRNA ratio SPTLC3:SPTLC1 
was 23-fold higher than the ratio SPTLC2:SPTLC1, suggest-
ing that placentas are enriched in the SPTLC3 subunit, as 
previously reported (Hornemann et al., 2006) (Figure 3A). 
As expected, when evaluating the protein levels, SPTLC1 
was higher than the other subunits (Figure 3B), as deter-
mined by densitometric analysis of Western blotting 
bands. Second, at the aim of evaluating the contribution 
of de novo synthesis of sphingolipids to the measured 
ceramide accumulation, we compared the transcription 
of the three subunits in placentas from vaginal deliver-
ies (both spontaneous and induced group) versus elec-
tive cesarean section (Figure 3C). We observed that in 
the induced group, SPTLC1, 2 and 3 mRNA levels were 
up-regulated by more than twofold (*p < 0.05; **p < 0.01 vs. 
cesarean, Dunnet post-test) while the spontaneous group 
increased by three-fold in SPTLC3 mRNA level only. The 
transcript upregulation correlates with a significant raise 
in protein expression (Western blotting analysis) for both 
SPTLC1 and 3 subunits of the enzyme (Figure 3D; *p < 0.05; 
**p < 0.01 vs. cesarean, Dunnet post- test).
SPT mRNA and protein expression inversely 
correlate with labor duration
We have observed that labor-related inflammation 
inversely correlates with the labor duration (Figure 1B) 
and that SPT is upregulated in the inflammatory process 
(Figure 3). Therefore, we investigated whether there was a 
correlation between SPT subunits expression and the dura-
tion of labor as well as the inflammatory status. SPTLC1 
mRNA level (Figure 4A) significantly decreased along with 
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Figure 3: Serine palmitoyl transferase (SPT) subunits are over-
expressed in placentas from spontaneous and induced as compared 
to cesarean parturition.
Panel (A) reports the normalization of mRNA value of SPTLC2 and 
3 subunits to the expression level of SPTLC1 mRNA in the control 
cesarean group. In panel (B), the basal protein expression of the 
three subunits in the elective cesarean group is represented. 
SPTLC1, 2, 3 mRNA expression (panel C) and protein content 
(panel D, expressed as ODu*mm2 from optical densitometry of 
Western Blotting protein bands) in placenta collected from women 
with spontaneous or induced onset of labor or from women who 
underwent cesarean parturition. Data on the graphs (C, D) are 
expressed as fold increase vs. ct (cesarean parturition, stated 
as  = 1). Western blotting images referred to the most representa-
tive ones out of two/three independent analysis. RT-PCR determi-
nation of each sample was performed in triplicate. Significance 
was evaluated by one-way ANOVA: panel (B), p = 0.0001; panel 
(C), p = 0.044 for SPTLC1 and p = 0.006 and for both SPTLC2 and 
SPTLC3 mRNA; panel (D), p = 0.048 and p = 0.002 for SPTLC1 and 
SPTLC3 protein, respectively; *p < 0.05 and **p < 0.01 vs. ct (Dunnett 
post-test).
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labor duration (p = 0.013) and the protein expression level 
(Figure 4B) showed the same trend, though statistically 
not significant. Furthermore, both mRNA and protein 
levels increased accordingly to the protein content of IL-6, 
one of the prevalent marker of inflammation in placenta 
(Figure 5A; p = 0.032, Figure 5B; p = 0.008). We did not find 
any correlation with either the duration of labor nor the 
level of IL-6 protein for SPTLC2 and 3 subunits at both 
transcriptional and transductional level (data not shown).
Discussion
To the best of our knowledge, we reported for the first time 
that ceramide content and expression of SPT (rate limiting 
enzyme for de novo ceramide synthesis) are increased in 
labored with respect to the cesarean placentas and that 
SPT expression directly correlates with inflammation and 
inversely with labor duration.
Parturition is characterized by a complex of transcrip-
tionally regulated events that include NF-κB activation 
and inflammatory mediators as well as multiple contrac-
tile genes transcription (Haddad et al., 2006; Christiaens 
et al., 2008; Eddama et al., 2009). Dysregulation of this 
mechanism and abnormal, increased or early inflam-
mation characterize parturition complications, such us 
pre term birth and preeclampsia  (Subramaniam et  al., 
2013; Zhang et  al., 2013). During normal pregnancy, 
the maternal immune response is highly controlled by 
a complex of cytokines that protects the fetus and pro-
motes the development of the placenta. The resolution 
of inflammation, that characterizes the first and the last 
stage of gestation, plays an important role in the success 
of pregnancy. As reviewed by Chatterjee et  al. (2014), 
this anti-inflammatory activity is largely mediated by 
IL-4 and IL-10.
Under the control of progesterone, IL-4 is produced by 
T–helper 2 (Th-2) immune cells of the placenta, by mater-
nal decidua and by maternal and fetal endothelial cells. 
IL-10 is constitutively expressed in placental villous troph-
oblast and additionally it is released by uterine NK cells, 
monocytes and T-regs in the decidua. It increases in the 
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first and second trimesters and it decreases prior to labor 
and delivery of the fetus.
Data presented in this manuscript assess the concept 
of a transcriptional program, involving the enhancement 
of the sphingolipid synthesis and its related ceramide 
accumulation, regulating the inflammatory reaction of 
labor and delivery. We demonstrated that the inflam-
matory marker IL-6 is upregulated in labored placentas, 
collected from women with vaginal delivery, compared 
to placentas from women who underwent elective cesar-
ean section. Phillips et al., demonstrated a negative cor-
relation between inflammatory prostaglandins synthetic 
enzymes expression and the duration of labor in term 
and preterm gestations, suggesting that transcriptionally 
regulation of inflammatory related genes affects parturi-
tion in terms of prolonged stressful labor (Phillips et al., 
2014). In agreement with the hypothesis of an acute and 
self resolving inflammation characterizing the physiol-
ogy of labor, we showed that IL-6 cytokine expression 
inversely correlates with labor duration, ranging from 1 h 
to 10 h. This observation suggests that a robust inflam-
matory mediators release facilitates the expulsion of a 
viable offspring. It has been reported that sphingolipid 
metabolism is finely regulated at the maternal-embryonic 
interface and that sphingolipid mediators take part to 
the first inflammatory phase of blastocyst implantation 
and to the acute late inflammation of labor and delivery 
(Kaneko-Tarui et al., 2007). Accordingly, in placenta from 
spontaneous and induced onset of labor, we observed a 
significant increase in ceramide content and we found 
that labor associated increase of IL-6 expression correlates 
with total ceramide content up-regulation. In addition we 
observed a slight decrease in sphingosine in inflamed 
placentas and no significant changes in the other sphin-
golipids, such as sphingomyelins and hexosyl-ceramides, 
among the different patient groups, confirming the 
hypothesis that ceramide accumulation occurs mainly 
because of an increased synthesis instead of catabolism 
of more complex sphingolipids. The accumulation of 
ceramide likely derives from a transcriptionally regulated 
enhancement of de novo sphingolipids synthesis, since 
we observed a significant increase of mRNA and protein 
expression of SPT (the enzyme responsible for the rate-
limiting step in the de novo synthesis of ceramide) in pla-
centa from spontaneous and induced parturition. SPT is 
composed of the SPTLC1 subunit forming an active heter-
odimer with SPTLC 2 or 3. It has been suggested that, while 
SPTLC1 acts as an anchor for the other subunits, SPTLC2 
and SPTLC3 combine alternatively in the complex, play 
specific functional role and offer a limiting factor for the 
enzymatic activity depending on their relative amount in 
the tissue (Hornemann et al., 2006). Here we reported that 
both SPTLC1 and SPTLC3 subunit expression increased 
in labored placentas, suggesting that the formation of 
this heterodimer occurs and SPTLC3 might represent the 
limiting factor of SPT activity. Although placentas are 
enriched in SPTLC3, we observed that SPTLC1 is the most 
representative, at the protein level, among the three subu-
nits in placentas from cesarean section. To note, SPTLC1 
is also the unique subunit whose transcript and protein 
content are highly dependent on the labor acute inflam-
mation (IL-6 cytokine content). According to this hypoth-
esis, we have recently demonstrated (Caretti et al., 2014) 
that de novo sphingolipid synthesis is involved in acute 
inflammation and that pharmacological inhibition of SPT 
activity down regulates the inflammatory response. The 
present results showed that both SPT and IL-6 enhanced 
transcription are inversely related to labor length. This is 
particularly interesting when considering that fast labor 
is desirable for both mother and fetus and that preterm 
labor is initiated by inflammatory cascades (Romero et al., 
2014). The data presented are underpinning a complex 
molecular mechanism driving not only labor development 
but also the whole inflammatory processes along gesta-
tion. Placenta expression of PGE2 at labor onset is under 
control of pro-inflammatory transcriptional factors (such 
as NF-κB) that can be activated by ceramide, among other 
mediators. In this view, transcriptional activation of cera-
mide synthesis can be hypothesized as part of the early 
events orchestrating the inflammatory response of partu-
rition. Our data raise the question of possible association 
between altered sphingolipid metabolism and gestation/
parturition defects and most important provide new per-
spective for investigation of a potential molecular target 
for the therapy of preterm birth.
Materials and methods
Case selection
Thirty-one normal-shaped, singleton placentas were obtained at the 
time of uncomplicated term delivery from nonsmoking women with 
uneventful pregnancies. Seven placentas were from women who 
underwent an elective cesarean section (‘cesarean’ group), consid-
ered as the control group for all further analysis. Six placentas were 
from women with spontaneous onset of labor (‘spontaneous’ group). 
Eighteen placentas were collected from women with induction of 
labor (‘induced’ group) performed according to the Bishop score. 
Exclusion criteria were gestational age  < 37 weeks and any maternal 
or fetal diseases or labor complication. Cesarean section were made 
for fetal breech presentation or for uterine scar due to previous sur-
gery. Cases selection was made by matching patients for maternal 
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and fetal characteristics. Maternal age, pre-pregnancy body mass 
index, and neonatal birth weight were similar between the three 
groups (Table 1). No woman received medications during pregnancy 
and/or epidural analgesia and/or antibiotics during labor. For each 
woman who had vaginal delivery (both spontaneous and induced 
group) we evaluated the duration (expressed in minutes) of the active 
phase of labor.
Placental sampling
Samples from grossly unremarkable placental parenchyma were 
 randomly collected immediately after delivery in midway between 
the chorionic and basal plates; samples were washed in phosphate-
buffered saline solution to remove maternal blood, immediately 
 frozen in liquid nitrogen, and stored at -80°C for further processing,
Reagents and antibodies
The synthetic oligonucleotides used in this study were purchased 
from M-Medical (Milan, Italy). The following primary antibodies 
and dilutions were used: anti-SPTLC1, 1:1000 (ab176706, Abcam, 
Cambridge, UK); anti-SPTLC2, 1.5 μg/ml (ab23696, Abcam, Cam-
bridge, UK); anti-SPTLC3, 1:250 (HPA044247, Sigma, St. Louis, MO, 
USA); anti-β-actin, 1:5000 (A5316, Sigma, St. Louis, MO, USA). The 
secondary antibodies (1:10 000) were from Jackson Laboratories 
(Bar Harbor, ME, USA). All reagents were of the maximal available 
purity degree.
IL-6 and TNF-α cytokine determination
Human placenta samples were homogenized in phosphate saline 
buffer (PBS) containing protease inhibitors (Roche Italia, Milan, Italy) 
by using a tissue homogenizer. Part of the homogenates was centri-
fuged at 1200 g for 30 min at 4°C and the supernatants were used for 
cytokines analysis. IL-6 and TNF-α were determined by LaboSpace 
(Milan, Italy) by means of biomarker multiplex immunoassays that 
measure the levels of multiple proteins in a single sample volume 
using the bead-based multiplex solution by the Luminex® Platform. 
Determinations have been performed in  triplicate.
LC–MS analysis
Sphingolipids from human placenta samples (ceramide, sphingomy-
elins and cerebrosides) were extracted by the Bligh-Dyer extraction 
method (Bligh and Dyer, 1959). Sphingolipid extracts, fortified with 
internal standards (N-dodecanoylsphingosine, N-dodecanoylgluco-
sylsphingosine, and N-dodecanoylsphingosylphosphorylcholine, 
0.2 nmol each), were prepared as previously described (Merrill et al., 
2005) and analyzed. The liquid chromatography-mass spectrometer 
consisted of a Waters Aquity UPLC system connected to a Waters 
LCT Premier orthogonal accelerated time of flight mass spectrom-
eter (Waters, Millford, MA, USA), operated in positive electrospray 
ionization mode. Full scan spectra from 50 to 1500 Da were acquired 
and individual spectra were summed to produce data points each 
0.2 s. Mass accuracy and reproducibility were maintained by using 
an independent reference spray by the LockSpray interference. The 
analytical column was a 100 mml 2.1  mm i.d., 1.7  mm C8 Acquity 
UPLC BEH (Waters). The two mobile phases were phase A: metha-
nol; phase B: water, both contained 0.2% formic acid (v/v) and 2 mm 
ammonium formate. A linear gradient was programed: 0.0 min: 20% 
B; 3 min: 10% B; 6 min: 10% B; 15 min: 1% B; 18 min: 1% B; 20 min: 
20% B; 22 min: 20% B. The flow rate was 0.3 ml/min. The column was 
held at 30°C. Quantification was carried out using the extracted ion 
chromatogram of each compound, using 50 mDa windows. The lin-
ear dynamic range was determined by injecting standard mixtures. 
 Positive identification of compounds was based on the accurate 
mass measurement with an error  < 5 ppm and its LC retention time, 
 compared to that of a standard (2%).
Western blotting
Human placenta samples were homogenized in phosphate buffered 
saline (PBS) containing proteases inhibitors (Roche Italia, Milan, 
Italy) by using a tissue homogenizer and spun at 1200 g for 30 min at 
4°C. An aliquot of the homogenate was used for protein quantifica-
tion by means of the Coomassie Blue kit (Bio-Rad Laboratories Italia, 
Milan, Italy) according to manufacturer’s instructions. The remain-
ing homogenate was resuspended in Laemmli buffer, boiled for 8 min 
and stored at -20°C. Equal amount of proteins (50 μg for SPTLC 1, 2, 
3) were separated on 8% acryl amide gels by SDS-electrophoresis and 
transferred onto nitrocellulose membranes. After blocking unspecific 
binding sites with 5% dry skimmed milk in TBS-Tween 0.1% (TBST), 
Table 1: Clinical characteristics.
  Cesarean   Spontaneous   Induced
Sampling   n = 7   n = 6   n = 18
Maternal age (years)   32.4±2.8   29.7±2.4   32.1±1.2
Gestational age (weeks)   38.6±0.3   39.0±0.3   40.0±0.3
Pre-pregnancy BMI (kg/m2)   21.6±1.7   22.6±1.5   22.3±0.7
Duration of active labor (min)   –   230.7±87.9   333.7±34.4
Neonatal birth-weight (g)   3221.4±170.6   3271.4±203.8   3339.4±84.7
Neonatal blood pH at birth   7.33±0.01   7.25±0.04   7.26±0.01
Clinical characteristics of the three experimental groups: cesarean group (women who underwent an elective cesarean section), spontane-
ous group (women with spontaneous onset of labor) and induced group (women with induction of labor). Data are expressed as mean±SEM. 
Data among the three experimental groups do not differ significantly (p = NS, one-way ANOVA test). BMI, Body mass index.
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the membranes were incubated (4°C/overnight) with primary anti-
bodies diluted in TBST, followed by incubation (room temperature/1 
h) with the appropriate HRP-secondary antibody diluted in TBST-
5% dry skimmed milk. The same membranes were immunoblotted 
against β-actin for data  normalization. Proteins were detected by 
chemiluminescence and bands intensity was quantified by Gel Doc 
2000, using Quantity One Software (BioRad Life Science, Hercules, 
CA, USA). Western blotting analysis has been repeated twice/three-
fold for all the samples belonging to the three experimental groups.
RNA extraction and quantitative RT-PCR
Total RNA was extracted and reverse transcribed according to the 
manufacturer’s instructions (Promega, Madison, WI, USA). Briefly, 
placenta’s biopsies were homogenized in 175 μl of lysis buffer by 
using a tissue homogenizer, placed in a heated Thermoblock at 70°C 
for 3 min and then centrifuged at 1200 g for 10 min at room tempera-
ture. The lysates were then cleared by 95% ethanol, transferred to 
spin basket assembly, centrifuged and the eluate discarded. After 
incubation at room temperature for 15  min with DNAse mix, the 
lysates were washed, centrifuged and the eluate discarded. Nuclease 
free water was then applied to the membrane to elute the RNA, stored 
at -80°C until used. The amplification of target genes (IL-6, TNF-α, 
SPTLC 1, SPTLC 2, SPTLC 3: primer sequences as previously reported 
(Hornemann et al., 2006; Dechecchi et al., 2011) was performed using 
the Syber Green system (Qiagen, Milan, Italy). Relative mRNA expres-
sion of target genes was normalized to the endogenous GAPDH con-
trol gene and results calculated by 2-ΔΔCt method (Arocho et al., 2006), 
as labored vs. control cesarean placentas. RT-PCR determinations 
were performed in triplicate.
Statistical analysis
The reported results are the mean value obtained from all the pla-
centa samples belonging to each experimental patient group. In 
case of Western blotting, we showed the most representative images. 
Data significance was evaluated by one-way ANOVA followed by the 
Dunnett post-test (all vs. cesarean group) when significant (p < 0.05). 
Linear correlation analysis was performed by the parametric Pearson 
method (significant when p < 0.05). Data are expressed as mean±SEM. 
Data analysis was performed by GraphPad Instat (La Jolla, CA, USA) 
software.
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